EE04643B1 - Osteoprotegeriin - Google Patents

Osteoprotegeriin

Info

Publication number
EE04643B1
EE04643B1 EE9700164A EE9700164A EE04643B1 EE 04643 B1 EE04643 B1 EE 04643B1 EE 9700164 A EE9700164 A EE 9700164A EE 9700164 A EE9700164 A EE 9700164A EE 04643 B1 EE04643 B1 EE 04643B1
Authority
EE
Estonia
Prior art keywords
osteoprotegerin
Prior art date
Application number
EE9700164A
Other languages
English (en)
Estonian (et)
Other versions
EE9700164A (et
Inventor
J. Boyle William
L. Lacey David
J. Calzone Frank
Chang Ming-Shi
Original Assignee
Amgen Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/577,788 external-priority patent/US6613544B1/en
Application filed by Amgen Inc. filed Critical Amgen Inc.
Publication of EE9700164A publication Critical patent/EE9700164A/xx
Publication of EE04643B1 publication Critical patent/EE04643B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
EE9700164A 1995-12-22 1996-12-20 Osteoprotegeriin EE04643B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/577,788 US6613544B1 (en) 1995-12-22 1995-12-22 Osteoprotegerin
US08/706,945 US6369027B1 (en) 1995-12-22 1996-09-03 Osteoprotegerin
PCT/US1996/020621 WO1997023614A1 (fr) 1995-12-22 1996-12-20 Osteoprotegerine

Publications (2)

Publication Number Publication Date
EE9700164A EE9700164A (et) 1998-02-16
EE04643B1 true EE04643B1 (et) 2006-06-15

Family

ID=27077338

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700164A EE04643B1 (et) 1995-12-22 1996-12-20 Osteoprotegeriin

Country Status (31)

Country Link
US (1) US6369027B1 (fr)
EP (4) EP2332974A3 (fr)
JP (1) JP4657388B2 (fr)
KR (1) KR100463584B1 (fr)
CN (1) CN1318588C (fr)
AR (1) AR004400A1 (fr)
AT (1) ATE409745T1 (fr)
AU (1) AU710587B2 (fr)
BG (1) BG63347B1 (fr)
CA (1) CA2210467C (fr)
CZ (1) CZ292587B6 (fr)
DE (1) DE19654610A1 (fr)
DK (1) DK0784093T3 (fr)
EE (1) EE04643B1 (fr)
ES (1) ES2316152T3 (fr)
FR (1) FR2742767B1 (fr)
GB (1) GB2312899B (fr)
HK (1) HK1001526A1 (fr)
HU (1) HU227482B1 (fr)
IL (1) IL121520A (fr)
MX (1) MX9706193A (fr)
NO (1) NO973699L (fr)
NZ (2) NZ326579A (fr)
PL (1) PL187408B1 (fr)
PT (1) PT784093E (fr)
RO (1) RO121386B1 (fr)
SI (1) SI0784093T1 (fr)
SK (1) SK110797A3 (fr)
TR (1) TR199601036A2 (fr)
WO (1) WO1997023614A1 (fr)
YU (1) YU69196A (fr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US6919434B1 (en) 1995-02-20 2005-07-19 Sankyo Co., Ltd. Monoclonal antibodies that bind OCIF
US7078493B1 (en) 1995-03-15 2006-07-18 Human Genome Sciences, Inc. Antibodies to human tumor necrosis factor receptor-like genes
US7632922B1 (en) * 1995-12-22 2009-12-15 Amgen, Inc. Osteoprotegerin
US7005413B1 (en) 1995-12-22 2006-02-28 Amgen Inc. Combination therapy for conditions leading to bone loss
JPH1057071A (ja) * 1996-08-19 1998-03-03 Snow Brand Milk Prod Co Ltd 新規ｄｎａ及びそれを用いた蛋白質の製造方法
JP4771563B2 (ja) 1996-12-06 2011-09-14 アムジエン・インコーポレーテツド Ｉｌ−１媒介疾患を処置するためにｉｌ−１インヒビターを使用する組合せ療法
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
JP2002509431A (ja) * 1996-12-23 2002-03-26 イミュネックス・コーポレーション ＮＦ−κＢのレセプター活性化因子−レセプターはＴＮＦレセプタースーパーファミリーの一員である−
RU2238949C2 (ru) * 1997-04-15 2004-10-27 Санкио Компани Лимитед Белок, специфически связывающийся с ингибирующим остеокластогенез фактором (ocif) (варианты), днк его кодирующая (варианты), днк в качестве зонда (варианты), способ получения белка (варианты), способ скрининга вещества (варианты), антитело (варианты), способ получения поликлонального антитела, гибридома (варианты), способ получения моноклонального антитела, способ измерения ocif-связывающего белка, фармацевтическая композиция (варианты) и лекарственное средство (варианты)
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
CZ302262B6 (cs) 1997-04-16 2011-01-19 Amgen Inc. Izolovaná nukleová kyselina, polypeptid kódovaný touto nukleovou kyselinou, expresní vektor obsahující tuto nukleovou kyselinu, hostitelská bunka transfekovaná tímto expresním vektorem, izolovaný protein vázající osteoprotegerin, protilátka vázající
JP2002514079A (ja) * 1997-05-01 2002-05-14 アムジエン・インコーポレーテツド キメラｏｐｇポリペプチド
WO1999004001A1 (fr) * 1997-07-21 1999-01-28 Zymogenetics, Inc. Recepteur ztnfr-5 du facteur de necrose tumorale
JP2001512667A (ja) * 1997-08-06 2001-08-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトオーファンレセプターｎｔｒ−１
US6346388B1 (en) 1997-08-13 2002-02-12 Smithkline Beecham Corporation Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2
WO1999011790A1 (fr) * 1997-09-04 1999-03-11 Zymogenetics, Inc. Recepteur ztnfr-6 du facteur de necrose des tumeurs
ATE393222T1 (de) 1997-09-18 2008-05-15 Genentech Inc Dcr3 polypeptid, ein tnfr homolog
CA2269114A1 (fr) * 1997-09-24 1999-03-24 Snow Brand Milk Products Co., Ltd. Methode de diagnostic de maladies metaboliques des os
US6087555A (en) * 1997-10-15 2000-07-11 Amgen Inc. Mice lacking expression of osteoprotegerin
JPH11155420A (ja) * 1997-12-02 1999-06-15 Snow Brand Milk Prod Co Ltd トランスジェニック動物
WO1999031128A2 (fr) * 1997-12-16 1999-06-24 Incyte Pharmaceuticals, Inc. Proteines du type facteur humain de necrose tumorale r2
US6077689A (en) * 1997-12-24 2000-06-20 Amgen Inc. Enhanced solubility of recombinant proteins
EP1054961A2 (fr) * 1998-02-17 2000-11-29 Incyte Pharmaceuticals, Inc. Proteine de la famille des recepteurs a chaine courte humains du tnf
US6103472A (en) * 1998-02-20 2000-08-15 Amgen Inc. Methods and compositions for identifying novel secreted mammalian polypeptides in yeast
US6150098A (en) * 1998-02-20 2000-11-21 Amgen Inc. Methods for identifying novel secreted mammalian polypeptides
US6790823B1 (en) * 1998-04-23 2004-09-14 Amgen Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
WO1999054360A1 (fr) 1998-04-23 1999-10-28 Ajinomoto Co., Inc. Substance possedant une activite antithrombotique et procede de detection de glycokallidine
EP2009025B1 (fr) 1998-05-14 2011-07-27 Immunex Corporation Procédé d'inhibition de l'activité des ostéoclastes
US6210924B1 (en) 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
IL141588A0 (en) 1998-09-15 2002-03-10 M & E Biotech As Method for down-regulating osteoprotegerin ligand activity
US6420339B1 (en) 1998-10-14 2002-07-16 Amgen Inc. Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
AU773891C (en) 1998-10-23 2005-02-17 Kirin-Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
CA2347107A1 (fr) * 1998-10-28 2000-05-04 Shinichi Mochizuki Agents therapeutiques pour deformations osseuses
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
WO2000042216A2 (fr) * 1999-01-18 2000-07-20 Osteometer Biotech A/S Predisposition genetique
US20030007972A1 (en) * 1999-02-24 2003-01-09 Edward Tobinick Cytokine antagonists and other biologics for the treatment of bone metastases
US7259253B2 (en) * 1999-05-14 2007-08-21 Quark Biotech, Inc. Genes associated with mechanical stress, expression products therefrom, and uses thereof
WO2001003719A2 (fr) * 1999-07-09 2001-01-18 Amgen Inc. Polytherapie destinee a des affections entrainant une perte osseuse
AUPQ167599A0 (en) * 1999-07-19 1999-08-12 St. Vincent's Institute Of Medical Research Inhibitor of osteoclast precursor formation
IL130989A0 (en) 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing
US6673771B1 (en) * 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
US8106098B2 (en) 1999-08-09 2012-01-31 The General Hospital Corporation Protein conjugates with a water-soluble biocompatible, biodegradable polymer
AU6946300A (en) * 1999-08-30 2001-03-26 Mayo Foundation For Medical Education And Research Use of dna encoding osteoprotegerin to prevent or inhibit metabolic bone disorders
US20030144187A1 (en) * 1999-09-03 2003-07-31 Colin R. Dunstan Opg fusion protein compositions and methods
AU2005237128B2 (en) * 1999-09-03 2008-09-11 Amgen Inc. Compositions and Methods for the Prevention or Treatment of Cancer and Bone Loss Associated with Cancer
EP1140136B1 (fr) * 1999-09-03 2007-05-16 Amgen Inc. Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer
US6808902B1 (en) * 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
EP1238077A1 (fr) * 1999-12-16 2002-09-11 Amgen Inc., Molecules de type tnfr/opg et leurs utilisations
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
PT2077279E (pt) 2000-06-28 2012-09-14 Amgen Inc Moléculas do receptor de linfopoietina estromal tímica e suas utilizações
ES2208145T3 (es) * 2000-09-22 2007-12-16 Immunex Corporation Ensayos de seleccion para agonistas o antagonistas del receptor activador de nf-kb.
AU2002231602A1 (en) * 2001-02-09 2002-08-28 Maxygen Holdings Ltd. Rank ligand-binding polypeptides
PT1757619E (pt) 2001-04-03 2010-03-25 Nestle Sa Osteoprotegerina no leite
WO2002098362A2 (fr) * 2001-06-06 2002-12-12 Immunex Corporation Utilisation d'antagonistes rank dans le traitement du cancer
MXPA04000134A (es) 2001-06-26 2005-06-06 Abgenix Inc Anticuerpos para ligandos de osteoprotegerina.
EP1270015A3 (fr) * 2001-06-29 2004-02-25 Sankyo Company Limited Un complexe de OCIF et de polysaccharide
KR100427299B1 (ko) * 2001-08-10 2004-04-14 한국생명공학연구원 인체 골 재흡수 억제인자（ｈＯＰＧ）를 생산하는 재조합플라스미드 ｐＧＨＯＰＧ（ＫＣＴＣ １０１９ＢＰ）
US20030049694A1 (en) * 2001-09-10 2003-03-13 Chung-Hsiun Wu Production of fusion proteins and use for identifying binding molecules
US6800462B2 (en) * 2001-09-10 2004-10-05 Abgenomics Corporation Production of recombinant proteins in vivo and use for generating antibodies
US7205275B2 (en) 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
JP4336467B2 (ja) * 2001-10-15 2009-09-30 株式会社林原生物化学研究所 破骨細胞形成抑制因子の産生を調節し得る物質のスクリーニング方法
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
AU2003243139B2 (en) * 2002-04-05 2007-06-21 Amgen Inc. Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors
US20080249068A1 (en) * 2002-09-05 2008-10-09 Deluca Hector F Method of Extending the Dose Range of Vitamin D Compounds
US7259143B2 (en) * 2002-09-05 2007-08-21 Wisconsin Alumni Research Foundation Method of extending the dose range of vitamin D compounds
AU2003297833A1 (en) 2002-12-10 2004-06-30 Schering-Plough Ltd. Canine rankl and methods for preparing and using the same
TWI293882B (en) 2003-03-24 2008-03-01 Sankyo Co Polymeric modifiers and pharmaceutical compositions
MX2007000216A (es) 2004-07-08 2007-03-15 Amgen Inc Peptidos terapeuticos.
NZ554390A (en) * 2004-12-13 2010-07-30 Cephalon Australia Vic Pty Ltd Osteoprotegerin variant proteins
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
AU2008262490B2 (en) 2007-05-22 2011-11-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
WO2011020047A1 (fr) 2009-08-14 2011-02-17 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Utilisation d'il-15 pour améliorer la production thymique et pour traiter la lymphopénie
EP2621515B1 (fr) 2010-09-28 2017-03-29 Aegerion Pharmaceuticals, Inc. Un polypeptide leptine chimèrique pinnipède-humain avec solubilité elevé
DK2764565T3 (da) 2011-10-05 2023-04-17 Oned Mat Inc Aktive siliciumnanostrukturmaterialer til lithiumionbatterier og fremgangsmåder, sammensætninger, komponenter og anordninger i forbindelser dermed
MX357291B (es) * 2012-03-31 2018-07-04 R Pharm Cjsc Closed Joint Stock Company Composicion derivada de osteoprotegerina y su uso.
US11680101B2 (en) 2017-01-27 2023-06-20 Kymab Limited Anti-OPG antibodies
JP6550413B2 (ja) * 2017-02-24 2019-07-24 アール−ファーム・インターナショナル・リミテッド・ライアビリティ・カンパニーＲ−Ｐｈａｒｍ Ｉｎｔｅｒｎａｔｉｏｎａｌ， Ｌｌｃ オステオプロテゲリン由来の組成物およびその使用
CN111004318B (zh) * 2019-12-30 2022-03-04 北京博康健基因科技有限公司 rhPTH(1-34)蛋白原液的纯化方法
TW202203964A (zh) 2020-04-17 2022-02-01 小利蘭史丹佛大學董事會 用於生物醫藥調配物之聚合物賦形劑

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
US4710473A (en) 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
FR2640537B1 (fr) 1988-12-21 1992-02-21 Levy Guy Installation et procede utilisant l'effet laser, pour la coupe ou la vaporisation de materiaux et tissus divers
ATE135370T1 (de) 1988-12-22 1996-03-15 Kirin Amgen Inc Chemisch modifizierte granulocytenkolonie erregender faktor
JP2877509B2 (ja) 1989-05-19 1999-03-31 アムジエン・インコーポレーテツド メタロプロテイナーゼ阻害剤
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2068389A1 (fr) * 1991-05-13 1992-11-14 Masahiko Sato Methode d'inhibition de la resorption osseuse
US5447851B1 (en) 1992-04-02 1999-07-06 Univ Texas System Board Of Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JP3284481B2 (ja) 1993-08-20 2002-05-20 本田技研工業株式会社 車両用油圧作動式変速機の油圧制御回路
US6268212B1 (en) 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression
JP3433495B2 (ja) 1993-12-30 2003-08-04 カシオ計算機株式会社 表示制御装置および表示制御方法
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
IL117175A (en) 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
WO1996028546A1 (fr) 1995-03-15 1996-09-19 Human Genome Sciences, Inc. Recepteur humain du facteur de necrose tumorale
US8615703B2 (en) 2010-06-04 2013-12-24 Micron Technology, Inc. Advanced bitwise operations and apparatus in a multi-level system with nonvolatile memory

Also Published As

Publication number Publication date
CN1182452A (zh) 1998-05-20
AR004400A1 (es) 1998-11-04
CZ292587B6 (cs) 2003-10-15
NO973699L (no) 1997-10-21
EP2332974A3 (fr) 2012-01-11
BG101813A (en) 1998-09-30
TR199601036A2 (tr) 1997-07-21
GB2312899B (en) 1999-05-05
IL121520A (en) 2010-11-30
YU69196A (en) 1999-11-22
HK1001526A1 (en) 1998-06-26
HUP9801122A2 (hu) 1998-08-28
PL187408B1 (pl) 2004-07-30
SI0784093T1 (sl) 2009-04-30
AU710587B2 (en) 1999-09-23
US6369027B1 (en) 2002-04-09
EP1990415A1 (fr) 2008-11-12
GB9626618D0 (en) 1997-02-05
JPH11503616A (ja) 1999-03-30
ATE409745T1 (de) 2008-10-15
EP2332974A2 (fr) 2011-06-15
CZ253897A3 (cs) 1999-03-17
EP0870023A1 (fr) 1998-10-14
EP0784093B1 (fr) 2008-10-01
GB2312899A (en) 1997-11-12
PL321938A1 (en) 1998-01-05
DE19654610A1 (de) 1997-06-26
FR2742767A1 (fr) 1997-06-27
EP0784093A1 (fr) 1997-07-16
JP4657388B2 (ja) 2011-03-23
BG63347B1 (bg) 2001-10-31
PT784093E (pt) 2008-12-17
TR199601036A3 (fr) 1997-07-21
ES2316152T3 (es) 2009-04-01
MX9706193A (es) 1997-11-29
CA2210467A1 (fr) 1997-07-03
FR2742767B1 (fr) 2001-03-30
KR19980703599A (ko) 1998-12-05
HU227482B1 (en) 2011-07-28
AU1468697A (en) 1997-07-17
CA2210467C (fr) 2011-02-08
HUP9801122A3 (en) 2000-09-28
WO1997023614A1 (fr) 1997-07-03
NZ332915A (en) 2000-07-28
NZ326579A (en) 1999-01-28
CN1318588C (zh) 2007-05-30
KR100463584B1 (ko) 2005-06-07
DK0784093T3 (da) 2008-12-15
SK110797A3 (en) 1999-07-12
EE9700164A (et) 1998-02-16
NO973699D0 (no) 1997-08-12
RO121386B1 (ro) 2007-04-30

Similar Documents

Publication Publication Date Title
DE69637695D1 (de) Osteoprotegerin
DK0784093T3 (da) Osteoprotegerin
DE69621152D1 (de) Schnittstellenpruefadapter
ATA135896A (de) Skibob
NO964334D0 (no) Sulfonylaminopyrimidiner
ATE198470T1 (de) Alkenyl-benzoylguanidine
FI960423A0 (fi) 4-merkapto-bentsoyyliguanidiinijohdannaiset
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
BR9501643A (pt) Helistato
ID17460A (id) Osteoprotegerin
SE9501817D0 (sv) När/långsyntssimdykningsglasögon
KR960028533U (ko) ＂t＂ 자
FI2171U1 (fi) Foertillverkat plattelement
SE9501165D0 (sv) Hållaranordning
BR7501858U (pt) Tellelight
BR9500075A (pt) Carrapetilha
FIU950420U0 (fi) Skyddsskal foer flaska
SE9500405D0 (sv) Flänsslang
FIU950435U0 (fi) Underlag
FIU950438U0 (fi) Ramfoersett skivformat stycke
NO952899D0 (no) Etektromotor
BR7500040U (pt) Raquet mastit
BR9501962A (pt) Lotofone
BR7500192U (pt) Parasitofiltro

Legal Events

Date Code Title Description
HD1A Correction of address
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20131220